Healthcare provider profile · identity verified

Jun Yang

Internal Medicine · NEW ROCHELLE, NY · NPI 1184922890

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	645	232
Levothyroxine Sodium	Levothyroxine Sodium	427	141
Lisinopril	Lisinopril	329	122
Losartan Potassium	Losartan Potassium	297	118
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	269	64
Amlodipine Besylate	Amlodipine Besylate	228	92
Trazodone Hcl	Trazodone Hcl	188	68
Fluticasone Propionate	Fluticasone Propionate	166	57
Hydrochlorothiazide	Hydrochlorothiazide	163	65
Gabapentin	Gabapentin	141	47
Atenolol	Atenolol	140	52
Simvastatin	Simvastatin	136	45
Albuterol Sulfate Hfa	Albuterol Sulfate	130	65
Alendronate Sodium	Alendronate Sodium	130	50
Omeprazole	Omeprazole	126	46
Pantoprazole Sodium	Pantoprazole Sodium	108	32
Metoprolol Tartrate	Metoprolol Tartrate	105	40
Lorazepam	Lorazepam	104	32
Tamsulosin Hcl	Tamsulosin Hcl	104	41
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	97	16
Metformin Hcl	Metformin Hcl	96	35
Citalopram Hbr	Citalopram Hydrobromide	92	32
Metoprolol Succinate	Metoprolol Succinate	90	30
Acyclovir	Acyclovir	89	30
Famotidine	Famotidine	86	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	84	35
Meloxicam	Meloxicam	82	29
Fluoxetine Hcl	Fluoxetine Hcl	71	27
Lovastatin	Lovastatin	67	23
Wixela Inhub	Fluticasone Propion/Salmeterol	67	27
Alvesco	Ciclesonide	58	25
Pravastatin Sodium	Pravastatin Sodium	56	21
Allopurinol	Allopurinol	55	23
Furosemide	Furosemide	55	27
Ibuprofen	Ibuprofen	52	20
Oxycodone Hcl	Oxycodone Hcl	52	13
Metformin Hcl Er	Metformin Hcl	50	22
Sertraline Hcl	Sertraline Hcl	49	13
Sumatriptan Succinate	Sumatriptan Succinate	49	13
Glipizide	Glipizide	48	21
Rosuvastatin Calcium	Rosuvastatin Calcium	47	19
Triamcinolone Acetonide	Triamcinolone Acetonide	47	30
Temazepam	Temazepam	45	suppressed
Duloxetine Hcl	Duloxetine Hcl	42	14
Spironolactone	Spironolactone	42	19
Clopidogrel	Clopidogrel Bisulfate	40	13
Baclofen	Baclofen	39	15
Terazosin Hcl	Terazosin Hcl	38	15
Acetaminophen-Codeine	Acetaminophen With Codeine	37	14
Cephalexin	Cephalexin	37	31
Montelukast Sodium	Montelukast Sodium	37	12
Spiriva Respimat	Tiotropium Bromide	35	suppressed
Tramadol Hcl	Tramadol Hcl	35	11
Azelastine Hcl	Azelastine Hcl	34	suppressed
Carvedilol	Carvedilol	33	12
Ondansetron Hcl	Ondansetron Hcl	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	33	12
Verapamil Er	Verapamil Hcl	33	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	33	suppressed
Azithromycin	Azithromycin	32	22
Doxycycline Monohydrate	Doxycycline Monohydrate	31	20
Potassium Chloride	Potassium Chloride	31	13
Nortriptyline Hcl	Nortriptyline Hcl	28	suppressed
Ondansetron Odt	Ondansetron	27	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	25	13
Bupropion Xl	Bupropion Hcl	25	suppressed
Colchicine	Colchicine	25	12
Prednisone	Prednisone	25	20
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	25	suppressed
Digoxin	Digoxin	24	suppressed
Eliquis	Apixaban	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	23	11
Nabumetone	Nabumetone	22	12
Ozempic	Semaglutide	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Atrovent Hfa	Ipratropium Bromide	20	suppressed
Calcitonin-Salmon	Calcitonin,salmon,synthetic	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Hydrocortisone	Hydrocortisone	20	11
Metronidazole	Metronidazole	20	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Alclometasone Dipropionate	Alclometasone Dipropionate	19	suppressed
Finasteride	Finasteride	19	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	18	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Testosterone	Testosterone	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Diazepam	Diazepam	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Torsemide	Torsemide	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Fluocinonide	Fluocinonide	14	14
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Morphine Sulfate Er	Morphine Sulfate	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Trospium Chloride	Trospium Chloride	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Epinephrine	Epinephrine	13	11
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Retin-A	Tretinoin	13	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Oxycontin	Oxycodone Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error